Mitoxantrone in NMO Spectrum Disorder in a Large Multicenter Cohort in French Caribbean

Discussion
MiTX is an effective and safe treatment for most of our patients, drastically less expensive than new molecules, and could be allowed in NMOSD Afro-descendant patients in geographical areas where access to care is difficult.

Source: Neurology Neuroimmunology and Neuroinflammation - November 10, 2023 Category: Neurology Authors: Chaumont, H., Berard, N., Karam, J.-P., Lobjois, Q., Tressieres, B., Signate, A., Lannuzel, A., Cabre, P. Tags: Cost effectiveness/economic, All Demyelinating disease (CNS), Devic's syndrome, Transverse myelitis Research Article Source Type: research